Altre lingue Balaxi Pharmaceuticals Limited

Azioni

BALAXI

INE618N01022

Mercato chiuso - NSE India S.E. Altri mercati azionari 13:47:53 21/06/2024			Variaz. 5gg	Var. 1 gen.
120,4 ^INR	-3,52%		-0,41%	+39,29%

29/05	Balaxi Pharmaceuticals Limited riporta i risultati degli utili per il quarto trimestre e l'intero anno terminato il 31 marzo 2024	CI
09/05	Balaxi Pharmaceuticals Limited nomina Mahesh Inani come Responsabile della conformità	CI

Altre lingue

Sblocca tutte le notizie: sii il primo a essere informato e reagisci prima dei mercati!

Registrazione 100% gratuita

Balaxi Pharmaceuticals Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024	29/05
Balaxi Pharmaceuticals Limited Appoints Mahesh Inani as the Compliance Officer	09/05
Balaxi Pharmaceuticals Limited Announces Resignation of Purnima Singh Kamble as Independent Director	08/05
Balaxi Pharmaceuticals Limited Announces Resignation of Udayan Shukla as Company Secretary and Compliance Officer	04/05
Balaxi Pharmaceuticals Limited Incorporates New Wholly Owned Subsidiary in Chile	14/02
Balaxi Pharmaceuticals Limited Announces Update on Company's Pharmaceutical Formulation Plant	09/02
Balaxi Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	09/02
Balaxi Pharmaceuticals Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	02/11
Balaxi Pharmaceuticals Limited completed the acquisition of Balaxi Healthcare Ecuador S.A.S.	01/10/23
Balaxi Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended June 30, 2023	03/08/23
Balaxi Pharmaceuticals Limited agreed to acquire Balaxi Healthcare Ecuador S.A.S. for $0.04 million.	03/08/23
Balaxi Pharmaceuticals Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2023	29/05/23
Balaxi Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022	01/02/23
Balaxi Pharmaceuticals : Certificate under SEBI (Depositories and Participants) Regulations, 2018	10/01/23
Balaxi Pharmaceuticals Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022	05/11/22
Balaxi Pharmaceuticals : Press Release	05/09/22
Balaxi Pharmaceuticals : Extra Ordinary Meeting	05/09/22
Balaxi Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended June 30, 2022	02/08/22
Balaxi Pharmaceuticals Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2022	23/05/22
Balaxi Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2021	09/02/22

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Balaxi Pharmaceuticals Limited

Azioni

BALAXI

INE618N01022

Altre lingue

Filtri